On September 7, 2012, Ruehter, Gerd; Koch, Uwe; Nussbaumer, Peter; Schultz-Fademrecht, Carsten; Eickhoff, Jan published a patent.Reference of 6,7-Dihydro-5H-pyrrolo[3,4-d]pyrimidine hydrochloride The title of the patent was Pharmaceutically active disubstituted triazine derivatives. And the patent contained the following:
The invention discloses disubstituted triazine derivatives and/or pharmaceutically acceptable salts and the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, immunol. diseases, autoimmune diseases, cardiovascular diseases, cell proliferative diseases, inflammation, erectile dysfunction and stroke, and pharmaceutical compositions containing at least one of said disubstituted triazine derivatives and/or pharmaceutically acceptable salts,. Furthermore, the invention relates to the use of said disubstituted triazine derivatives as inhibitors for a protein kinase and the preparation of said compounds The experimental process involved the reaction of 6,7-Dihydro-5H-pyrrolo[3,4-d]pyrimidine hydrochloride(cas: 1187830-46-1).Reference of 6,7-Dihydro-5H-pyrrolo[3,4-d]pyrimidine hydrochloride
The Article related to triazine derivative infection immune autoimmune cardiovascular proliferation disease preparation, erectile dysfunction stroke triazine derivative protein kinase inhibitor and other aspects.Reference of 6,7-Dihydro-5H-pyrrolo[3,4-d]pyrimidine hydrochloride
Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia